Laman UtamaEWL • ETR
add
Edwards Lifesciences Corp
Tutup sebelumnya
€68.18
Julat tahun
€62.00 - €76.02
Permodalan pasaran
48.52B USD
Bilangan Purata
474.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NYSE
Dalam berita
MarketWatch
11 jam lalu
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
5.56%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2026info | Perubahan T/T |
|---|---|---|
Hasil | 1.65B | 16.70% |
Perbelanjaan pengendalian | — | — |
Pendapatan bersih | — | — |
Margin untung bersih | 23.09 | -8.88% |
Pendapatan bagi setiap syer | 0.78 | 21.88% |
EBITDA | — | — |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2026info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | — | — |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | — | — |
Syer tertunggak | — | — |
Harga kepada buku | — | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 11.65% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2026info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | — | — |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland. Wikipedia
Diasaskan
1958
Ibu pejabat
Tapak web
Pekerja
16,000
